ArticleEJHaem2023

Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation.

Rebecca W Silbermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.